Prescriber's Corner
Ofatumumab
Christopher Campen, PharmD, BCPS
From the University of Arizona College of Pharmacy and Arizona Cancer Center, Tucson, Arizona.
The author has no conflicts of interest to disclose.
Correspondence to: Christopher Campen, PharmD, BCPS, Pharmacy-Pulido Center, 1295 N. Martin Avenue, P.O. Box 210202, Tucson, AZ 85721.
E-mail: chriscampen@gmail.com
J Adv Pract Oncol 2010;1:125–128 |
DOI: 10.6004/jadpro.2010.1.2.16 |
© 2010 Harborside Press
For access to the full length article, please
sign in.